IPD — ImpediMed Cashflow Statement
0.000.00%
Last trade - 00:00- AU$14.64m
- AU$15.95m
- AU$14.61m
Annual cashflow statement for ImpediMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | C2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -18.8 | -19.7 | -21.7 | -19.9 | -19.7 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -15.7 | -18 | -17.8 | -15.6 | -17.9 |
| Capital Expenditures | -5.22 | -6.04 | -3.1 | -0.989 | -1.27 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | 0.972 | 0.718 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.22 | -6.04 | -3.1 | -0.017 | -0.553 |
| Financing Cash Flow Items | -2.21 | -1.67 | -0.062 | -1.9 | -4.66 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 39.9 | 27.9 | -0.481 | 13.6 | 13 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21 | 4.98 | -21.1 | -2.45 | -6.9 |